Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Hepatic Porphyria Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 350 Mg
1.2.3 313 Mg
1.3 Market by Application
1.3.1 Global Acute Hepatic Porphyria Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Acute Hepatic Porphyria Drug Market Perspective (2018-2029)
2.2 Global Acute Hepatic Porphyria Drug Growth Trends by Region
2.2.1 Acute Hepatic Porphyria Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Acute Hepatic Porphyria Drug Historic Market Size by Region (2018-2024)
2.2.3 Acute Hepatic Porphyria Drug Forecasted Market Size by Region (2024-2029)
2.3 Acute Hepatic Porphyria Drug Market Dynamics
2.3.1 Acute Hepatic Porphyria Drug Industry Trends
2.3.2 Acute Hepatic Porphyria Drug Market Drivers
2.3.3 Acute Hepatic Porphyria Drug Market Challenges
2.3.4 Acute Hepatic Porphyria Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Acute Hepatic Porphyria Drug by Players
3.1.1 Global Acute Hepatic Porphyria Drug Revenue by Players (2018-2024)
3.1.2 Global Acute Hepatic Porphyria Drug Revenue Market Share by Players (2018-2024)
3.2 Global Acute Hepatic Porphyria Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Acute Hepatic Porphyria Drug, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Acute Hepatic Porphyria Drug Market Concentration Ratio
3.4.1 Global Acute Hepatic Porphyria Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Hepatic Porphyria Drug Revenue in 2022
3.5 Global Key Players of Acute Hepatic Porphyria Drug Head office and Area Served
3.6 Global Key Players of Acute Hepatic Porphyria Drug, Product and Application
3.7 Global Key Players of Acute Hepatic Porphyria Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Acute Hepatic Porphyria Drug Breakdown Data by Type
4.1 Global Acute Hepatic Porphyria Drug Historic Market Size by Type (2018-2024)
4.2 Global Acute Hepatic Porphyria Drug Forecasted Market Size by Type (2024-2029)
5 Acute Hepatic Porphyria Drug Breakdown Data by Application
5.1 Global Acute Hepatic Porphyria Drug Historic Market Size by Application (2018-2024)
5.2 Global Acute Hepatic Porphyria Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Acute Hepatic Porphyria Drug Market Size (2018-2029)
6.2 North America Acute Hepatic Porphyria Drug Market Size by Type
6.2.1 North America Acute Hepatic Porphyria Drug Market Size by Type (2018-2024)
6.2.2 North America Acute Hepatic Porphyria Drug Market Size by Type (2024-2029)
6.2.3 North America Acute Hepatic Porphyria Drug Market Share by Type (2018-2029)
6.3 North America Acute Hepatic Porphyria Drug Market Size by Application
6.3.1 North America Acute Hepatic Porphyria Drug Market Size by Application (2018-2024)
6.3.2 North America Acute Hepatic Porphyria Drug Market Size by Application (2024-2029)
6.3.3 North America Acute Hepatic Porphyria Drug Market Share by Application (2018-2029)
6.4 North America Acute Hepatic Porphyria Drug Market Size by Country
6.4.1 North America Acute Hepatic Porphyria Drug Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Acute Hepatic Porphyria Drug Market Size by Country (2018-2024)
6.4.3 North America Acute Hepatic Porphyria Drug Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Acute Hepatic Porphyria Drug Market Size (2018-2029)
7.2 Europe Acute Hepatic Porphyria Drug Market Size by Type
7.2.1 Europe Acute Hepatic Porphyria Drug Market Size by Type (2018-2024)
7.2.2 Europe Acute Hepatic Porphyria Drug Market Size by Type (2024-2029)
7.2.3 Europe Acute Hepatic Porphyria Drug Market Share by Type (2018-2029)
7.3 Europe Acute Hepatic Porphyria Drug Market Size by Application
7.3.1 Europe Acute Hepatic Porphyria Drug Market Size by Application (2018-2024)
7.3.2 Europe Acute Hepatic Porphyria Drug Market Size by Application (2024-2029)
7.3.3 Europe Acute Hepatic Porphyria Drug Market Share by Application (2018-2029)
7.4 Europe Acute Hepatic Porphyria Drug Market Size by Country
7.4.1 Europe Acute Hepatic Porphyria Drug Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Acute Hepatic Porphyria Drug Market Size by Country (2018-2024)
7.4.3 Europe Acute Hepatic Porphyria Drug Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Acute Hepatic Porphyria Drug Market Size (2018-2029)
8.2 China Acute Hepatic Porphyria Drug Market Size by Type
8.2.1 China Acute Hepatic Porphyria Drug Market Size by Type (2018-2024)
8.2.2 China Acute Hepatic Porphyria Drug Market Size by Type (2024-2029)
8.2.3 China Acute Hepatic Porphyria Drug Market Share by Type (2018-2029)
8.3 China Acute Hepatic Porphyria Drug Market Size by Application
8.3.1 China Acute Hepatic Porphyria Drug Market Size by Application (2018-2024)
8.3.2 China Acute Hepatic Porphyria Drug Market Size by Application (2024-2029)
8.3.3 China Acute Hepatic Porphyria Drug Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Acute Hepatic Porphyria Drug Market Size (2018-2029)
9.2 Asia Acute Hepatic Porphyria Drug Market Size by Type
9.2.1 Asia Acute Hepatic Porphyria Drug Market Size by Type (2018-2024)
9.2.2 Asia Acute Hepatic Porphyria Drug Market Size by Type (2024-2029)
9.2.3 Asia Acute Hepatic Porphyria Drug Market Share by Type (2018-2029)
9.3 Asia Acute Hepatic Porphyria Drug Market Size by Application
9.3.1 Asia Acute Hepatic Porphyria Drug Market Size by Application (2018-2024)
9.3.2 Asia Acute Hepatic Porphyria Drug Market Size by Application (2024-2029)
9.3.3 Asia Acute Hepatic Porphyria Drug Market Share by Application (2018-2029)
9.4 Asia Acute Hepatic Porphyria Drug Market Size by Region
9.4.1 Asia Acute Hepatic Porphyria Drug Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Acute Hepatic Porphyria Drug Market Size by Region (2018-2024)
9.4.3 Asia Acute Hepatic Porphyria Drug Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Acute Hepatic Porphyria Drug Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Acute Hepatic Porphyria Drug Market Size by Type
10.2.1 Middle East, Africa, and Latin America Acute Hepatic Porphyria Drug Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Acute Hepatic Porphyria Drug Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Acute Hepatic Porphyria Drug Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Acute Hepatic Porphyria Drug Market Size by Application
10.3.1 Middle East, Africa, and Latin America Acute Hepatic Porphyria Drug Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Acute Hepatic Porphyria Drug Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Acute Hepatic Porphyria Drug Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Acute Hepatic Porphyria Drug Market Size by Country
10.4.1 Middle East, Africa, and Latin America Acute Hepatic Porphyria Drug Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Acute Hepatic Porphyria Drug Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Acute Hepatic Porphyria Drug Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Alnylam Pharmaceuticals
11.1.1 Alnylam Pharmaceuticals Company Details
11.1.2 Alnylam Pharmaceuticals Business Overview
11.1.3 Alnylam Pharmaceuticals Acute Hepatic Porphyria Drug Introduction
11.1.4 Alnylam Pharmaceuticals Revenue in Acute Hepatic Porphyria Drug Business (2018-2024)
11.1.5 Alnylam Pharmaceuticals Recent Developments
11.2 Recordati Rare Diseases
11.2.1 Recordati Rare Diseases Company Details
11.2.2 Recordati Rare Diseases Business Overview
11.2.3 Recordati Rare Diseases Acute Hepatic Porphyria Drug Introduction
11.2.4 Recordati Rare Diseases Revenue in Acute Hepatic Porphyria Drug Business (2018-2024)
11.2.5 Recordati Rare Diseases Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Acute Hepatic Porphyria Drug Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of 350 Mg
Table 3. Key Players of 313 Mg
Table 4. Global Acute Hepatic Porphyria Drug Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Acute Hepatic Porphyria Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Acute Hepatic Porphyria Drug Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Acute Hepatic Porphyria Drug Market Share by Region (2018-2024)
Table 8. Global Acute Hepatic Porphyria Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Acute Hepatic Porphyria Drug Market Share by Region (2024-2029)
Table 10. Acute Hepatic Porphyria Drug Market Trends
Table 11. Acute Hepatic Porphyria Drug Market Drivers
Table 12. Acute Hepatic Porphyria Drug Market Challenges
Table 13. Acute Hepatic Porphyria Drug Market Restraints
Table 14. Global Acute Hepatic Porphyria Drug Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Acute Hepatic Porphyria Drug Revenue Share by Players (2018-2024)
Table 16. Global Top Acute Hepatic Porphyria Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Hepatic Porphyria Drug as of 2022)
Table 17. Global Acute Hepatic Porphyria Drug Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by Acute Hepatic Porphyria Drug Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of Acute Hepatic Porphyria Drug, Headquarters and Area Served
Table 20. Global Key Players of Acute Hepatic Porphyria Drug, Product and Application
Table 21. Global Key Players of Acute Hepatic Porphyria Drug, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Acute Hepatic Porphyria Drug Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Acute Hepatic Porphyria Drug Revenue Market Share by Type (2018-2024)
Table 25. Global Acute Hepatic Porphyria Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Acute Hepatic Porphyria Drug Revenue Market Share by Type (2024-2029)
Table 27. Global Acute Hepatic Porphyria Drug Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Acute Hepatic Porphyria Drug Revenue Share by Application (2018-2024)
Table 29. Global Acute Hepatic Porphyria Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Acute Hepatic Porphyria Drug Revenue Share by Application (2024-2029)
Table 31. North America Acute Hepatic Porphyria Drug Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America Acute Hepatic Porphyria Drug Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Acute Hepatic Porphyria Drug Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America Acute Hepatic Porphyria Drug Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Acute Hepatic Porphyria Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Acute Hepatic Porphyria Drug Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America Acute Hepatic Porphyria Drug Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Acute Hepatic Porphyria Drug Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe Acute Hepatic Porphyria Drug Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Acute Hepatic Porphyria Drug Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe Acute Hepatic Porphyria Drug Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Acute Hepatic Porphyria Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Acute Hepatic Porphyria Drug Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe Acute Hepatic Porphyria Drug Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Acute Hepatic Porphyria Drug Market Size by Type (2018-2024) & (US$ Million)
Table 46. China Acute Hepatic Porphyria Drug Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Acute Hepatic Porphyria Drug Market Size by Application (2018-2024) & (US$ Million)
Table 48. China Acute Hepatic Porphyria Drug Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Acute Hepatic Porphyria Drug Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia Acute Hepatic Porphyria Drug Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Acute Hepatic Porphyria Drug Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia Acute Hepatic Porphyria Drug Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Acute Hepatic Porphyria Drug Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Acute Hepatic Porphyria Drug Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia Acute Hepatic Porphyria Drug Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Acute Hepatic Porphyria Drug Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Acute Hepatic Porphyria Drug Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Acute Hepatic Porphyria Drug Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Acute Hepatic Porphyria Drug Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Acute Hepatic Porphyria Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Acute Hepatic Porphyria Drug Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Acute Hepatic Porphyria Drug Market Size by Country (2024-2029) & (US$ Million)
Table 63. Alnylam Pharmaceuticals Company Details
Table 64. Alnylam Pharmaceuticals Business Overview
Table 65. Alnylam Pharmaceuticals Acute Hepatic Porphyria Drug Product
Table 66. Alnylam Pharmaceuticals Revenue in Acute Hepatic Porphyria Drug Business (2018-2024) & (US$ Million)
Table 67. Alnylam Pharmaceuticals Recent Developments
Table 68. Recordati Rare Diseases Company Details
Table 69. Recordati Rare Diseases Business Overview
Table 70. Recordati Rare Diseases Acute Hepatic Porphyria Drug Product
Table 71. Recordati Rare Diseases Revenue in Acute Hepatic Porphyria Drug Business (2018-2024) & (US$ Million)
Table 72. Recordati Rare Diseases Recent Developments
Table 73. Research Programs/Design for This Report
Table 74. Key Data Information from Secondary Sources
Table 75. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Hepatic Porphyria Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Acute Hepatic Porphyria Drug Market Share by Type: 2022 VS 2029
Figure 3. 350 Mg Features
Figure 4. 313 Mg Features
Figure 5. Global Acute Hepatic Porphyria Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Acute Hepatic Porphyria Drug Market Share by Application: 2022 VS 2029
Figure 7. Hospital Pharmacy Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Online Pharmacy Case Studies
Figure 10. Others Case Studies
Figure 11. Acute Hepatic Porphyria Drug Report Years Considered
Figure 12. Global Acute Hepatic Porphyria Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Acute Hepatic Porphyria Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Acute Hepatic Porphyria Drug Market Share by Region: 2022 VS 2029
Figure 15. Global Acute Hepatic Porphyria Drug Market Share by Players in 2022
Figure 16. Global Top Acute Hepatic Porphyria Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Hepatic Porphyria Drug as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Acute Hepatic Porphyria Drug Revenue in 2022
Figure 18. North America Acute Hepatic Porphyria Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Acute Hepatic Porphyria Drug Market Share by Type (2018-2029)
Figure 20. North America Acute Hepatic Porphyria Drug Market Share by Application (2018-2029)
Figure 21. North America Acute Hepatic Porphyria Drug Market Share by Country (2018-2029)
Figure 22. United States Acute Hepatic Porphyria Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Acute Hepatic Porphyria Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Acute Hepatic Porphyria Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe Acute Hepatic Porphyria Drug Market Share by Type (2018-2029)
Figure 26. Europe Acute Hepatic Porphyria Drug Market Share by Application (2018-2029)
Figure 27. Europe Acute Hepatic Porphyria Drug Market Share by Country (2018-2029)
Figure 28. Germany Acute Hepatic Porphyria Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Acute Hepatic Porphyria Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Acute Hepatic Porphyria Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Acute Hepatic Porphyria Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Acute Hepatic Porphyria Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Acute Hepatic Porphyria Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. China Acute Hepatic Porphyria Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 35. China Acute Hepatic Porphyria Drug Market Share by Type (2018-2029)
Figure 36. China Acute Hepatic Porphyria Drug Market Share by Application (2018-2029)
Figure 37. Asia Acute Hepatic Porphyria Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 38. Asia Acute Hepatic Porphyria Drug Market Share by Type (2018-2029)
Figure 39. Asia Acute Hepatic Porphyria Drug Market Share by Application (2018-2029)
Figure 40. Asia Acute Hepatic Porphyria Drug Market Share by Region (2018-2029)
Figure 41. Japan Acute Hepatic Porphyria Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Acute Hepatic Porphyria Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. China Taiwan Acute Hepatic Porphyria Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Acute Hepatic Porphyria Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India Acute Hepatic Porphyria Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia Acute Hepatic Porphyria Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Acute Hepatic Porphyria Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Acute Hepatic Porphyria Drug Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America Acute Hepatic Porphyria Drug Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America Acute Hepatic Porphyria Drug Market Share by Country (2018-2029)
Figure 51. Brazil Acute Hepatic Porphyria Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico Acute Hepatic Porphyria Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Turkey Acute Hepatic Porphyria Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Acute Hepatic Porphyria Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Israel Acute Hepatic Porphyria Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GCC Countries Acute Hepatic Porphyria Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Alnylam Pharmaceuticals Revenue Growth Rate in Acute Hepatic Porphyria Drug Business (2018-2024)
Figure 58. Recordati Rare Diseases Revenue Growth Rate in Acute Hepatic Porphyria Drug Business (2018-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed